Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure
Publication date: June 2018 Source:European Journal of Cancer, Volume 96 Author(s): Andrea Necchi, Daniele Raggi, Patrizia Giannatempo, Alessandra Alessi, Gianluca Serafini, Maurizio Colecchia, Siraj M. Ali, Jon H. Chung
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου